Insider Transactions in Q1 2024 at Axonics, Inc. (AXNX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2024
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
11,288
-24.69%
|
$756,296
$67.74 P/Share
|
|
Jan 31
2024
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+37.56%
|
-
|
|
Jan 31
2024
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+25.03%
|
-
|
|
Jan 31
2024
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,161
-15.7%
|
$2,355,787
$67.74 P/Share
|
|
Jan 31
2024
|
Raymond W Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,400
+22.06%
|
-
|
|
Jan 31
2024
|
Kari Leigh Keese Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,489
-7.45%
|
$233,763
$67.74 P/Share
|
|
Jan 31
2024
|
Kari Leigh Keese Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,167
+11.64%
|
-
|
|
Jan 31
2024
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,615
-27.66%
|
$1,113,205
$67.74 P/Share
|
|
Jan 31
2024
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,500
+29.8%
|
-
|
|
Jan 31
2024
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
15,899
-17.04%
|
$1,065,233
$67.74 P/Share
|
|
Jan 31
2024
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+23.08%
|
-
|
|
Jan 08
2024
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,999
-46.76%
|
$1,103,931
$69.0 P/Share
|